Evaluation of Dipeptidyl Peptidase-IV Inhibitor Use in the Inpatient Setting.

Inpatient DPP-IV inhibitor use was associated with mean daily BG within goal range. Administering DPP-IV inhibitors in the inpatient setting should be considered in hospitalized patients with controlled T2DM.